The company manufactures the CO2 Heart Laser System, which is used by cardiac surgeons for carbon dioxide transmyocardial revascularization (TMR) to alleviate severe angina symptoms. Viveve Medical also offers RenalGuard, a product designed to reduce the toxic effects of contrast media on the kidneys during medical imaging procedures. The RenalGuard System includes a software-controlled console and single-use sets. In 2011, the company sold its Transmyocardial Revascularization (TMR) business. Overall, Viveve Medical develops medical equipment that aids in the treatment of cardiac and vascular conditions, ensuring patient safety by removing toxic contrast dyes that may harm the kidneys during imaging procedures.